Dialogues with experts "Arterial hypertension and the brain as a target organ"

Time codes:
  • 00:01:42

    Arterial hypertension is a leading factor in cardiovascular mortality

  • 00:03:38

    Hypertension is becoming more common in younger people due to stress and the pace of life

  • 00:04:38

    The brain is the first organ to suffer from hypertension

  • 00:05:20

    Cognitive impairment interferes with treatment adherence

  • 00:07:11

    Cognitive impairment in hypertension is possible at any age

  • 00:08:01

    The Montreal scale is the key to early diagnosis

  • 00:10:22

    When should a general practitioner refer a patient to a cardiologist?

  • 00:13:10

    Modern treatment of hypertension – starting with combination therapy

  • 00:14:54

    The need for neuroprotection in hypertension

  • 00:18:14

    Mexidol is a multimodal drug with proven efficacy

Vadim Vitalievich Tyrenko , MD, Professor, Head of the Department of Faculty Therapy at the S.M. Kirov Military Medical Academy, Chief Cardiologist of the Russian Ministry of Defense, and Chief Pulmonologist of the Healthcare Committee of the Government of St. Petersburg.

Evgeniya Viktorovna Ekusheva , Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation at the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia.

Announcement:

The new episode of the program “Dialogue with Experts” discusses the current problem of arterial hypertension (AH) and its impact on the body.

Main topics:

  • Hypertension is a global problem, despite the arsenal of drugs.
  • Early signs of brain damage in hypertension: cognitive impairment, fatigue, distracted attention.
  • Modern methods of diagnosing cognitive disorders (Montreal scale, attention tests).
  • "Roadmap" of a patient with arterial hypertension. Criteria for resistant hypertension.
  • Treatment strategies: combination treatment, importance of neuroprotection.
  • The role of Mexidol in brain protection: results of the MEMO study, safety and efficacy.
  • An integrated approach: not only pressure control, but also protection of target organs.
Time codes:
  • 00:01:42

    Arterial hypertension is a leading factor in cardiovascular mortality

  • 00:03:38

    Hypertension is becoming more common in younger people due to stress and the pace of life

  • 00:04:38

    The brain is the first organ to suffer from hypertension

  • 00:05:20

    Cognitive impairment interferes with treatment adherence

  • 00:07:11

    Cognitive impairment in hypertension is possible at any age

  • 00:08:01

    The Montreal scale is the key to early diagnosis

  • 00:10:22

    When should a general practitioner refer a patient to a cardiologist?

  • 00:13:10

    Modern treatment of hypertension – starting with combination therapy

  • 00:14:54

    The need for neuroprotection in hypertension

  • 00:18:14

    Mexidol is a multimodal drug with proven efficacy

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com